| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/20/2013 | CN102977056A Synthesis method of N-carbobenzoxy-3-fluoro-4-morpholinylaniline |
| 03/20/2013 | CN102977055A Method for separating piperazine |
| 03/20/2013 | CN101973963B Method for synthesizing 2, 2-dimorpholinyl diethyl ether by taking high-boiling morpholine as raw material |
| 03/20/2013 | CN101903094B Method for producing an amine |
| 03/20/2013 | CN101903092B Method for producing an amine |
| 03/20/2013 | CN101712659B Compound with platelet aggregation resisting activity and preparation method thereof |
| 03/20/2013 | CN101489981B Method for producing an amine |
| 03/20/2013 | CN101429164B Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 03/19/2013 | US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 03/19/2013 | US8399662 O-acyloxime derivatives, preparation method thereof, and pharmaceutical composition containing the same for prevention and treatment of cardiovascular disease |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| 03/19/2013 | US8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 03/19/2013 | US8399256 Method for introducing gene into cell, and composition for use in the method |
| 03/19/2013 | CA2719531C New ruthenium complexes as catalysts for metathesis reactions |
| 03/14/2013 | WO2013034756A1 Biphenyl compounds for use in treating malaria and other parasitic disorders |
| 03/14/2013 | US20130065917 Salt of naphthyridine carboxylic acid derivative |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130064770 Radiolabeled compounds and methods thereof |
| 03/13/2013 | CN102971330A Metal complexes of thiourea and their derivatives as metal delivering anti-cancer and anti-inflammatory agents |
| 03/13/2013 | CN102971291A Novel amide derivative and use thereof as medicine |
| 03/13/2013 | CN102964239A Metallo-beta-lactamase inhibitor |
| 03/13/2013 | CN102964196A Preparation method of nitrile compound |
| 03/13/2013 | CN102964195A Method for preparing second-level and third-level substituted amide |
| 03/13/2013 | CN102206196B Method for recovering morpholine from acidic waste water containing morpholine |
| 03/13/2013 | CN101631545B Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/13/2013 | CN101395129B Metal carboxylate salt nucleating or clarifying agent compounds and related polymer compositions and methods |
| 03/12/2013 | US8394954 Benzophenone hybrids as anticancer agents and processes for the preparation thereof |
| 03/12/2013 | US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/12/2013 | US8394804 Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | US8394799 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 03/07/2013 | US20130059862 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof |
| 03/07/2013 | US20130058990 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent |
| 03/06/2013 | EP2565183A1 Glycine transporter-1 inhibitors |
| 03/06/2013 | EP2563781A1 Processes for preparing linezolid |
| 03/06/2013 | CN102958892A Method for preparing chemical compounds of interest by aromatic nucleophilic substitution |
| 03/06/2013 | CN102952100A Method for separating ranolazine by adopting simulated moving bed |
| 03/06/2013 | CN102952099A Pyrrole ionic liquid, and preparation method and application thereof |
| 03/06/2013 | CN102952098A Pyrazine ionic liquid, and preparation method and application thereof |
| 03/06/2013 | CN102952097A Double-centre piperazine ionic liquid, and preparation method and application thereof |
| 03/06/2013 | CN102952096A Anhydrous piperazine preparation method |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389500 Fused heterocyclic compounds as ion channel modulators |
| 02/28/2013 | WO2013028543A1 Bax agonist, compositions, and methods related thereto |
| 02/28/2013 | WO2013027660A1 Pesticide |
| 02/28/2013 | US20130053400 Oligomer-antihistamine conjugates |
| 02/28/2013 | US20130053378 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use |
| 02/28/2013 | CA2848726A1 Bax agonist, compositions, and methods related thereto |
| 02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2013 | CN102947283A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 02/27/2013 | CN102942538A Substituted benzhydryl piperazine derivative and preparation method and application thereof |
| 02/27/2013 | CN102942500A Preparation method of N-formamide compound |
| 02/27/2013 | CN102941035A Gemini surface active agent using pyrrole ring as hydrophilic head group and preparation method of Gemini surface active agent using pyrrole ring as hydrophilic head group |
| 02/27/2013 | CN101289408B Non-steroid progestogen receptor regulator, preparation thereof, pharmaceutical compositions and uses |
| 02/26/2013 | US8383833 Method for producing optically active amino acid derivative |
| 02/21/2013 | WO2013023273A1 Piperazine derivatives |
| 02/21/2013 | WO2012026897A9 A process for the preparation of imatinib base |
| 02/21/2013 | CA2845030A1 Piperazine derivatives |
| 02/20/2013 | CN102936233A New crystal form of 1-[di(4- fluorophenyl)methyl]-4-(2,3,4-trimethyl phenyl) piperazine dihydrochloride |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/14/2013 | WO2013022550A2 Small molecule inhibitors of ebola and lassa fever viruses |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013021971A1 Organic photoelectric conversion element and organic solar cell employing same |
| 02/14/2013 | US20130041147 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | CN102933549A Process for preparing a cyclic tertiary methylamine |
| 02/13/2013 | CN102924750A Preparation method of non-metal phosphinate flame retardant |
| 02/13/2013 | CN102924567A Peptide compound and preparation method and use of peptide compound |
| 02/13/2013 | CN102924406A Substituted aryl oxygen ethylpiperazine derivative, preparation method of substituted aryl oxygen ethylpiperazine derivative and application of substituted aryl oxygen ethylpiperazine derivative |
| 02/13/2013 | CN102924286A Preparation method of N1-(2-aminoethyl)-1,2-ethylenediamine |
| 02/13/2013 | CN102921466A Heterogeneous Au/Ze-MOF catalyst and preparation method and application thereof |
| 02/12/2013 | US8372979 Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone |
| 02/12/2013 | CA2571587C Quaternary salt ccr2 antagonists |
| 02/12/2013 | CA2539059C Novel ligand activating receptors rars used for human medicine and cosmetics |
| 02/12/2013 | CA2529817C Novel antibacterial agents |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/07/2013 | WO2013019655A2 Vimentin as a biomarker for the progression of myeloproliferative neoplasms |
| 02/07/2013 | WO2013019462A1 Emm-23 molecular sieve material, its synthesis and use |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | CA2844120A1 Emm-23 molecular sieve material, its synthesis and use |
| 02/05/2013 | US8366956 Quaternary ammonium salt and composition, and electrochemical device |
| 02/05/2013 | CA2562401C Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 02/05/2013 | CA2299119C A method of stabilizing and/or isolating nucleic acids |
| 01/31/2013 | WO2013016677A1 N,n-dialkylalkylenyl esters, compositions thereof, and methods for use thereof |
| 01/31/2013 | US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130029992 N,n-dialkylalkylenyl esters, compositions thereof, and methods for use thereof |
| 01/31/2013 | US20130029943 Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries |
| 01/31/2013 | CA2843273A1 N,n-dialkylalkylenyl esters, compositions thereof, and methods for use thereof |
| 01/30/2013 | EP2550258A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/30/2013 | CN1997630B New disubstituted phenylpiperidines as modulators of dopamine neurotransmission |
| 01/30/2013 | CN102906078A Novel compound and use thereof |
| 01/30/2013 | CN102898404A Method for preparing bullomedil hydrochloride |
| 01/30/2013 | CN102898403A Method for preparing novel crystal form of 1-(bi(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxyphenyl)piperazine dihydrochloride |
| 01/30/2013 | CN102895974A Method for synthesizing N-methyl piperidine and supported catalyst used by the method |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362016 Phenyl propionic acids as PPAR delta activators |
| 01/29/2013 | US8362001 Azetidinyl diamides as monoacylglycerol lipase inhibitors |